A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.


Updates from The Motley Fool

Latest updates on Spectrum Pharmaceuticals from Fool.com.  The Fool has written over 100 articles on Spectrum Pharmaceuticals.
5 Worst Biotechs of 2013

A simple list of five of the worst biotech performers through May.

The Nasdaq's 5 Most Hated Stocks

Short-sellers are piling into these five most-hated Nasdaq components. Is their pessimism warranted?

This Week in Biotech

A look back at the biggest stories this week in biotech and what they mean for investors.



Stock Performance

View Interactive SPPI Charts
Sponsored by

Key Data Points

Primary metrics and data points about Spectrum Pharmaceuticals.
Current Price: $5.89
Prev Close: $5.75
Open: $5.78
Bid: $5.84
Ask: $5.93
Day's Range: $5.73 - $5.92
52wk Range: $3.21 - $7.74
Volume: 599,081
Avg Vol 563,391
Market Cap: $474M
P/E (ttm): -6.76
EPS (ttm): ($0.85)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Spectrum Pharmaceuticals.
CAPS Rating 4 out of 5
 
424 Outperform
12 Underperform
CAPS All Stars
 
42 Outperform
3 Underperform

How do you think Spectrum Pharmaceuticals will perform against the market?



You pick for Spectrum Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Rajesh C Shrotriya, CEO

33% Approve

Based on 13 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Spectrum Pharmaceuticals.

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers